Prof. Dr. Alessandro Prigione is a tenured Associate Professor in Pediatric Metabolic Medicine at the Medical Faculty of Heinrich Heine University in Düsseldorf, Germany. Previously, he was independent Team Leader at the Max Delbrueck Center for Molecular Medicine (MDC) in Berlin. The focus of Prigione's lab is to establish induced pluripotent stem cell (iPSC)-based approaches to modeling and treatment discovery for neurological diseases causing mitochondrial impairment. Dr. Prigione received his M.D. at the University of Milan, Italy, in 2002 and his Ph.D. at the San Raffaele Institute of Milan in 2008. During his Ph.D., Dr. Prigione worked on neurological diseases at the University of Milan-Bicocca and on mitochondrial disorders at the University of California in Davis, USA. As a postdoctoral scientist, Dr. Prigione worked on mouse iPSCs at the Stem Cell Research Institute in Milan and on human iPSCs at the Max Planck Institute for Molecular Genetics in Berlin.